Ganymed Pharmaceuticals AG
acquiredacquired
acquired
Stage
2001
Founded
1
Investors
About
Ganymed Pharmaceuticals AG was a biopharmaceutical company focused on developing a new class of antibody drugs for cancer treatment. The company was acquired by Astellas Pharma Inc. in 2016.
Explore Ganymed Pharmaceuticals AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.